Innovent’s Adalimumab And Bevacizumab Get New Indications In China

New Indications Include Treatment of Psoriasis, Uveitis And Glioblastoma

 
• By Akriti Seth
  
China - syringe
Innovent receives NMPA approval for new indications for its adalimumab and bevacizumab biosimilars • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products